Meril Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 62.10 Cr
as on 24-10-2024
- Paid Up Capital ₹ 6.06 Cr
as on 24-10-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 202.35 Cr
as on 24-10-2024
- Satisfied Charges ₹ 24.47 Cr
as on 24-10-2024
- Revenue 51.40%
(FY 2023)
- Profit 445.82%
(FY 2023)
- Ebitda 101.87%
(FY 2023)
- Net Worth 68.73%
(FY 2023)
- Total Assets 32.55%
(FY 2023)
About Meril Life Sciences India
The Corporate was formerly known as Interventional Technologies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 62.10 Cr and a paid-up capital of Rs 6.06 Cr.
The company currently has active open charges totaling ₹202.35 Cr. The company has closed loans amounting to ₹24.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Meril Life Sciences India Private Limited India is Rushi Sathe as COMPANY SECRETARY. Pramodkumar Minocha and Sanjay Shah serve as directors at the Company.
- CIN/LLPIN
U33110GJ1999PTC060787
- Company No.
060787
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 1999
- Date of AGM
21 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Meril Life Sciences India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rushi Sathe | Company Secretary | 01-Jun-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramodkumar Minocha  | Director | 01-Sep-2006 | Current |
| Sanjay Shah | Whole-Time Director | 13-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Meril Life Sciences India.
Meril Life Sciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 51.4% increase. The company also saw a substantial improvement in profitability, with a 445.82% increase in profit. The company's net worth Soared by an impressive increase of 68.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meril Life Sciences India?
In 2023, Meril Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Jun 2019 | ₹20.00 Cr | Open |
Others Creation Date: 24 Jul 2014 | ₹105.00 Cr | Open |
Dbs Bank Ltd Creation Date: 11 Jun 2014 | ₹20.00 Cr | Open |
How Many Employees Work at Meril Life Sciences India?
Unlock and access historical data on people associated with Meril Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meril Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meril Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
